Gene Query: TIMM10B

Dataset Description Geneva Score
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 24.91
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 21.85
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 20.15
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 20.15
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 13.97
Comprehensive comparative analysis of 5’ end RNA sequencing methods 13.2
Gene expression analysis of the impact of TDP-43 knockout in human cells. 12.56
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 11.32
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 11.32
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 11.24
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 10.79
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 10.76
IRF2 is a master regulator of human keratinocyte stem cell fate 10.76
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.04
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 9.69
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 9.53
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 9.46
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 9.25
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 9.0
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.89
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 8.89
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 8.88
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 8.55
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 8.43
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.25
RNAseq Study in CC-671 Treated Cal-51 Cells 8.24
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 7.9
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.61
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.61
Human HAP1 cells before and after nutrient deprivation 7.59
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 7.59
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 7.55
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.47
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.44
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 7.4
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 7.27
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 7.19
DRB/GRO-Seq -/+ UV 7.07
Spliceosomal disruption of the non-canonical BAF complex in cancer 7.01
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.99
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.85
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 6.8
FBXW7 modulates stress response by post-translational modification of HSF1 6.8
DART-seq: an antibody-free method for global m6A detection 6.79
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 6.72
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 6.57
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 6.43
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 6.31
Transcriptome sequencing of K-562 cells 6.22
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 6.22
TFAP2C signalling in human fibroblasts 6.17
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 6.12
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.91
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.91
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 5.87
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.84
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 5.75
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 5.71
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.52
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 5.22
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.19
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.19
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 5.16
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 5.16
MeRIP-seq for heat shock in B-cell lymphoma cells 5.07
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.05
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 5.03
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.99
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 4.99
RNA sequencing of BT142 and TS603 cell lines 4.99
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.97
RNA-seq of tumor cells following angiopellosis extravasation 4.92
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.89
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 4.89
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.89
AR-independent prostate cancer is sustained through FGF signaling 4.88
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.84
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 4.82
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.81
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.77
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 4.74
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.73
Human embryonic stem cells in E8 and AKIT culture medium 4.73
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.62
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.59
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.58
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.57
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.54
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.54
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.53
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.47
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.43
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.41
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.4
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.4
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.34
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.34
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 4.34
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 4.3
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 4.3
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 4.29
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 4.29
Gene expression changes after LOC550643 silencing 4.25
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 4.24
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.23
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.22
Transcriptional profiling of microglia; current state of the art and future perspectives 4.2
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.18
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.18
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 4.14
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 4.14
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 4.14
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.13
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.13
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.13
The evolution of N6-methyladenosine in primates 4.09
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.06
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 4.05
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.05
CROP-Seq in Primary Human T Cells 4.04
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.0
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.94
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.94
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.93
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.86
Zone dependent distinctive gene expression profile of the normal human liver tissue 3.86
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.85
Regulation of protein translation during mitosis 3.85
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.85
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 3.82
SLAM-seq for K562 endogenous mRNA decay 3.82
Effect of drugs on transcriptomic profiles 3.82
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.81
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 3.8
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 3.8
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.79
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 3.79
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 3.77
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.77
Rorc disruption in human FG pancreatic cancer cells 3.76
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.72
Next generation sequencing of small RNAs isolated from exosomes in human semen 3.7
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.68
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.65
Trans-differentiation of human adult peripheral blood T cells into neurons 3.65
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.65
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.64
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.63
RNA-Seq from human ILC transitional populations 3.63
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 3.63
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.62
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 3.61
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 3.6
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 3.57
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.55
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 3.55
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.54
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 3.54
snRNAs as regulators of alternative splicing 3.54
RNA-seq analysis of BAP1-depleted uveal melanoma cells 3.52
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.47
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.47
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 3.47
RNA-seq of young and quiescent MRC-5 human fibroblasts 3.46
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.45
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.43
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.43
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.42
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.41
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 3.4
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.39
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.39
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.39
Determination of tRNA aminoacylation levels by high throughput sequencing 3.37
The cohesin complex prevents Myc-induced replication stress 3.34
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.34
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.34
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.34
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 3.32
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 3.31
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.31
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 3.3
SUV420H2 knockdown in PANC-1 3.29
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.26
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.25
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.24
SLIGRL-induced gene expression changes in NHEK cells 3.22
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.19
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.19
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.19
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 3.18
Expression by CD133+ cells isolated from the adult human exocrine pancreas 3.16
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 3.16
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.16
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.15
BCL11B 3.14
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.14
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.14
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.14
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 3.13
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.13
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 3.12
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 3.12
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.12
Genome-wide analysis of the Integrator complex (HTS) 3.11
Genome-wide analysis of the Integrator complex 3.11
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 3.11
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.1
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.1
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 3.1
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 3.09
Identification of renal resident macrophages across species 3.09
Global analysis of enhancer targets: Mosaic-seq 3.09
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.07
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 3.06
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.06
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 3.06
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.04
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.04
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.96
Genome-wide chromatin analysis of Ewing sarcoma 2.94
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 2.94
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 2.93
Nutritional control of protein translation 2.92
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.89
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 2.89
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.88
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.87
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.87
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.86
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.86
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 2.84
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 2.84
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.84
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.8
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.8
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.79
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.78
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.77
Discovering human diabetes-risk gene function with genetics and physiological assays 2.75
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 2.74
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 2.72
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 2.72
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 2.72
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 2.72
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.71
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.7
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.7
Identification of global XBP1s target gene expression in human prostate cancer cells 2.69
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.69
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 2.69
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.67
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.6
Stem and effector CD8 T-cells from human cancers 2.58
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.54
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.54
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.54
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 2.53
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.52
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.51
Downregulation of DDX5/DDX17 and REST 2.51
Transcriptome analysis of CNS leukemia 2.47
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.47
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.47
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.46
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 2.46
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.46
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.44
RNA Seq of HMVEC under hypoxia 2.44
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.42
scRNASeq analysis of cycling cardiomyocytes 2.41
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.41
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.36
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 2.36
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.35
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.34
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 2.29
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.29
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.28
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.28
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.27
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.25
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.24
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.23
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.22
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.21
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.2
IMP3 regulated gene expression in breast cancer cells 2.2
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.19
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.19
Cajal bodies are linked to genome conformation [RNA-Seq] 2.19
Cajal bodies are linked to genome conformation 2.19
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.18
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.17
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.16
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 2.16
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.15
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.11
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.11
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.11
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.11
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.09
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.07
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.05
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.04
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 1.98
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 1.98
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.98
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.97
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.96
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.91
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 1.91
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.9
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.9
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.89
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.88
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.88
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.81
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.8
CD86 regulates a pro-survival signal in myeloma cells 1.79
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.79
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.78
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.77
NAPRT activation of macrophages 1.77
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.76
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.75
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.74
Effect of ILF3 on translation during homeostasis and the antiviral response 1.74
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.73
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.73
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.73
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.71
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.67
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.64
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.61
Functional significance of the HIV-1 Tat signature amino acid residues 1.59
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.53
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.51
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.48
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.48
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.47
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.46
A549 cell transcriptome responses to infection with H7N9 influenza virus 1.45
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.44
Human ovarian granulosa cell transcriptome 1.41
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.38
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.37
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.37
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.34
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.34
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.33
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.31
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.3
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.29
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.27
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.25
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.24
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.21
Genome-wide discovery of human splicing branchpoints 1.2
Identification of renal resident macrophages across species [C1] 1.19
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.18
Identification of a LIF-responsive replication-competent human β cell 1.18
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.17
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.16
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.15
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.14
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.14
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.14
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.13
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.12
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.12
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.11
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.1
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.09
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 1.08
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.07
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.07
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.06
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.06
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.06
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.05
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.04
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.99
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.98
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.98
High-throughput sequencing of PROMPT-enriched samples. 0.97
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.96
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.93
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.93
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.9
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.89
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.89
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.89
Loss of CREBBP results in gene expression repression in lymphoma cells 0.89
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.88
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.85
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.84
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.84
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 0.84
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.83
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.83
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.83
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.82
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.82
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.81
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.81
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.79
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.78
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.78
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 0.71
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 0.71
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.71
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.71
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.7
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.69
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.69
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.67
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.64
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.61
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.6
Transcriptional landscape changes during human embryonic stem cell derivation 0.59
High-resolution comparative analysis of great ape genomes 0.59
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.59
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.58
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.57
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.57
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.57
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.56
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.56
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.56
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 0.52
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.51
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.46
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.46
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.46
Cell responses to dysregulated VZV-induced cell-cell fusion 0.45
U1 snRNP telescripting regulates size-function stratified human genome 0.45
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.45
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.43
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.43
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.42
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.41
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.41
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.41
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.41
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.39
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.39
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.39
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.38
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.38
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.37
Gene expression activation in CLL mediated by MSCs contact 0.35
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.33
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.33
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.3
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.29
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 0.28
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.28
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.27
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.27
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.26
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.25
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.22
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.22
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.22
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.21
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.2
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.2
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.2
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.18
RNA-seq of IL-4 stimulated human keratinocytes 0.18
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.17
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.16
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.16
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.16
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.15
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.15
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.15
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.15
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.15
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.15
HBEC-shp53-PCHD7 0.14
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.14
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.14
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.13
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.09
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.09
HNRNPM-regulated splicing dependencies in prostate cancer 0.09
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.09
FOXP1 orchestration of ASD-relevant signaling pathways. 0.09
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.08
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.06
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.03
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.03
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.02
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.0
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation